Literature DB >> 32909150

GABAergic Interneuron and Neurotransmission Are mTOR-Dependently Disturbed in Experimental Focal Cortical Dysplasia.

Shaoping Zhong1, Zhihao Zhao2, Wanjing Xie1, Yiying Cai1, Yiying Zhang1, Jing Ding3, Xin Wang4,5.   

Abstract

Focal cortical dysplasia (FCD) is a major cause for drug-resistant epilepsies. The molecular and cellular mechanisms of epileptogenesis in FCD are still poorly understood. Some studies have suggested that deficiencies of γ-aminobutyric acid (GABA) system may play an important role in type II FCD, but it remains controversial. In order to examine whether and how GABAergic interneurons and synaptic function are affected, we generated a somatic mTOR hyperactivation-based mouse model of type II FCD by in utero electroporation, quantified densities of interneurons in the malformed cortices, and recorded miniature inhibitory postsynaptic currents in dysmorphic neurons. We detected 20-25% reduction of GABAergic interneurons within malformed cortices, independent of cortical regions and cell subtypes but proportionate to the decrease of global neuron counts. GABAergic synaptic transmission from interneurons to mTOR hyperactivated dysmorphic neurons was dramatically disrupted, outweighing the decrease of interneuron counts. Postnatal mTOR inhibition partially rescued these alterations of GABAergic system. We also quantified the expression of GABAA receptor, GABA transporter, and chloridion transporter encoding genes and found that their expression was relatively intact within the malformed cortices. Taken together, these results confirmed that GABAergic interneuron and synapse transmission are disturbed profoundly in an mTOR-dependent manner in type II FCD. Our study suggests that postsynaptic mechanisms independent of interneuron reduction or altered expression of GABA synapse genes might be accountable for the impaired GABAergic neurotransmission in type II FCD as well as other mTOR-related epilepsies.

Entities:  

Keywords:  Epilepsy; Focal cortical dysplasia; GABA; Interneuron; mTOR pathway

Mesh:

Substances:

Year:  2020        PMID: 32909150     DOI: 10.1007/s12035-020-02086-y

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  43 in total

1.  Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.

Authors:  Delia M Talos; Hongyu Sun; Bela Kosaras; Annelise Joseph; Rebecca D Folkerth; Annapurna Poduri; Joseph R Madsen; Peter M Black; Frances E Jensen
Journal:  Ann Neurol       Date:  2012-03-23       Impact factor: 10.422

2.  Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia.

Authors:  M Cecilia Ljungberg; Meenakshi B Bhattacharjee; Yaojuan Lu; Dawna L Armstrong; Daniel Yoshor; John W Swann; Michael Sheldon; Gabriella D'Arcangelo
Journal:  Ann Neurol       Date:  2006-10       Impact factor: 10.422

3.  Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations.

Authors:  Stéphanie Baulac; Saeko Ishida; Elise Marsan; Catherine Miquel; Arnaud Biraben; Dang Khoa Nguyen; Doug Nordli; Patrick Cossette; Sylvie Nguyen; Virginie Lambrecq; Mihaela Vlaicu; Maïlys Daniau; Franck Bielle; Eva Andermann; Frederick Andermann; Eric Leguern; Francine Chassoux; Fabienne Picard
Journal:  Ann Neurol       Date:  2015-03-13       Impact factor: 10.422

4.  Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia.

Authors:  P B Crino; A C Duhaime; G Baltuch; R White
Journal:  Neurology       Date:  2001-04-10       Impact factor: 9.910

5.  The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission.

Authors:  Ingmar Blümcke; Maria Thom; Eleonora Aronica; Dawna D Armstrong; Harry V Vinters; Andre Palmini; Thomas S Jacques; Giuliano Avanzini; A James Barkovich; Giorgio Battaglia; Albert Becker; Carlos Cepeda; Fernando Cendes; Nadia Colombo; Peter Crino; J Helen Cross; Olivier Delalande; François Dubeau; John Duncan; Renzo Guerrini; Philippe Kahane; Gary Mathern; Imad Najm; Ciğdem Ozkara; Charles Raybaud; Alfonso Represa; Steven N Roper; Noriko Salamon; Andreas Schulze-Bonhage; Laura Tassi; Annamaria Vezzani; Roberto Spreafico
Journal:  Epilepsia       Date:  2010-11-10       Impact factor: 5.864

6.  Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.

Authors:  Jae Seok Lim; Woo-il Kim; Hoon-Chul Kang; Se Hoon Kim; Ah Hyung Park; Eun Kyung Park; Young-Wook Cho; Sangwoo Kim; Ho Min Kim; Jeong A Kim; Junho Kim; Hwanseok Rhee; Seok-Gu Kang; Heung Dong Kim; Daesoo Kim; Dong-Seok Kim; Jeong Ho Lee
Journal:  Nat Med       Date:  2015-03-23       Impact factor: 53.440

7.  Dysfunction of synaptic inhibition in epilepsy associated with focal cortical dysplasia.

Authors:  Maria Elisa Calcagnotto; Mercedes F Paredes; Tarik Tihan; Nicholas M Barbaro; Scott C Baraban
Journal:  J Neurosci       Date:  2005-10-19       Impact factor: 6.167

8.  Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery.

Authors:  Ingmar Blumcke; Roberto Spreafico; Gerrit Haaker; Roland Coras; Katja Kobow; Christian G Bien; Margarete Pfäfflin; Christian Elger; Guido Widman; Johannes Schramm; Albert Becker; Kees P Braun; Frans Leijten; Johannes C Baayen; Eleonora Aronica; Francine Chassoux; Hajo Hamer; Hermann Stefan; Karl Rössler; Maria Thom; Matthew C Walker; Sanjay M Sisodiya; John S Duncan; Andrew W McEvoy; Tom Pieper; Hans Holthausen; Manfred Kudernatsch; H Joachim Meencke; Philippe Kahane; Andreas Schulze-Bonhage; Josef Zentner; Dieter H Heiland; Horst Urbach; Bernhard J Steinhoff; Thomas Bast; Laura Tassi; Giorgio Lo Russo; Cigdem Özkara; Buge Oz; Pavel Krsek; Silke Vogelgesang; Uwe Runge; Holger Lerche; Yvonne Weber; Mrinalini Honavar; José Pimentel; Alexis Arzimanoglou; Adriana Ulate-Campos; Soheyl Noachtar; Elisabeth Hartl; Olaf Schijns; Renzo Guerrini; Carmen Barba; Thomas S Jacques; J Helen Cross; Martha Feucht; Angelika Mühlebner; Thomas Grunwald; Eugen Trinka; Peter A Winkler; Antonio Gil-Nagel; Rafael Toledano Delgado; Thomas Mayer; Martin Lutz; Basilios Zountsas; Kyriakos Garganis; Felix Rosenow; Anke Hermsen; Tim J von Oertzen; Thomas L Diepgen; Giuliano Avanzini
Journal:  N Engl J Med       Date:  2017-10-26       Impact factor: 91.245

9.  Increased numbers of coassembled PSD-95 to NMDA-receptor subunits NR2B and NR1 in human epileptic cortical dysplasia.

Authors:  Zhong Ying; William Bingaman; Imad M Najm
Journal:  Epilepsia       Date:  2004-04       Impact factor: 5.864

10.  Dissecting the genetic basis of focal cortical dysplasia: a large cohort study.

Authors:  Sara Baldassari; Théo Ribierre; Elise Marsan; Homa Adle-Biassette; Sarah Ferrand-Sorbets; Christine Bulteau; Nathalie Dorison; Martine Fohlen; Marc Polivka; Sarah Weckhuysen; Georg Dorfmüller; Mathilde Chipaux; Stéphanie Baulac
Journal:  Acta Neuropathol       Date:  2019-08-23       Impact factor: 17.088

View more
  6 in total

1.  [Establishment of a system for regulating the gene expression of embryonic mouse cerebral cortex neural stem cells by in utero electroporation].

Authors:  Wei-Ming Ou; Long-Kai He; Xiao-Yu Wang; Xue-Song Yang; Guang Wang; Bing-Xiao Li; Ya Jin; Sha-Sha Han; Guo-Sheng Liu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022 Sept 15

2.  Expression of 4E-BP1 in juvenile mice alleviates mTOR-induced neuronal dysfunction and epilepsy.

Authors:  Lena H Nguyen; Youfen Xu; Travorn Mahadeo; Longbo Zhang; Tiffany V Lin; Heather A Born; Anne E Anderson; Angélique Bordey
Journal:  Brain       Date:  2022-05-24       Impact factor: 15.255

3.  Transcription Factor VAX1 Regulates the Regional Specification of the Subpallium Through Repressing Gsx2.

Authors:  Yan Wen; Zihao Su; Ziwu Wang; Lin Yang; Guoping Liu; Zicong Shang; Yangyang Duan; Heng Du; Zhenmeiyu Li; Yan You; Xiaosu Li; Zhengang Yang; Zhuangzhi Zhang
Journal:  Mol Neurobiol       Date:  2021-04-05       Impact factor: 5.590

4.  Upstream open reading frame with NOTCH2NLC GGC expansion generates polyglycine aggregates and disrupts nucleocytoplasmic transport: implications for polyglycine diseases.

Authors:  Shaoping Zhong; Yangye Lian; Wenyi Luo; Rongkui Luo; Xiaoling Wu; Jun Ji; Yuan Ji; Jing Ding; Xin Wang
Journal:  Acta Neuropathol       Date:  2021-10-25       Impact factor: 17.088

Review 5.  Investigating the Role of GABA in Neural Development and Disease Using Mice Lacking GAD67 or VGAT Genes.

Authors:  Erika Bolneo; Pak Yan S Chau; Peter G Noakes; Mark C Bellingham
Journal:  Int J Mol Sci       Date:  2022-07-19       Impact factor: 6.208

6.  Corrigendum: Convergent and Divergent Mechanisms of Epileptogenesis in mTORopathies.

Authors:  Lena H Nguyen; Angélique Bordey
Journal:  Front Neuroanat       Date:  2021-07-06       Impact factor: 3.856

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.